2027 ICD-10-CM Diagnosis Code L65.1Anagen effluvium
ICD-10-CM Codes›L00–L99›L60-L75›L65
- Billable — Valid for Submission
- Not Chronic
L65.1 is a billable ICD-10-CM diagnosis code for anagen effluvium. It is valid on HIPAA claims for fiscal year 2027 (October 1, 2026 through September 30, 2027) and groups to MS-DRG 606 through 607. Coders also document this condition as alopecia due to disturbance of hair cycle. In AHRQ's Clinical Classifications Software (CCSR), this diagnosis falls under Other specified and unspecified skin disorders.
Code Identity
Code Classification
Approximate SynonymsGuidance
Alternate terms and clinical phrases that map to this code.
- Alopecia due to disturbance of hair cycle
- Anagen effluvium
- Anagen effluvium caused by drug
- Drug-induced hair abnormality
- Short anagen syndrome
- Toxic anagen effluvium
Instructional NotesGuidance
Instructions from the official ICD-10-CM Tabular List that apply to L65.1: its own notes plus those printed at L65, block L60-L75, and Chapter 12. A note printed at a category, block or chapter applies to every code under it.
Excludes1
Not coded here: the excluded code is never reported together with this one, unless the two conditions are unrelated.
- congenital malformations of integument (Q84.-)
Excludes2
Not included here: the excluded condition is not part of this code, but a patient may have both, so both codes may be reported.
- certain conditions originating in the perinatal period (P04-P96)
- certain infectious and parasitic diseases (A00-B99)
- complications of pregnancy, childbirth and the puerperium (O00-O9A)
- congenital malformations, deformations, and chromosomal abnormalities (Q00-Q99)
- endocrine, nutritional and metabolic diseases (E00-E88)
- lipomelanotic reticulosis (I89.8)
- neoplasms (C00-D49)
- symptoms, signs and abnormal clinical and laboratory findings, not elsewhere classified (R00-R94)
- systemic connective tissue disorders (M30-M36)
- viral warts (B07.-)
Use Additional Code
Add a second code, after this one, to fully describe the condition.
Source: CMS ICD-10-CM Tabular List. How to read instructional notes.
Index to Diseases and InjuriesGuidance
Clinical ClassificationClinical
AHRQ’s CCSR groups this code into broader clinical categories.
Clinical InformationClinical
Anagen Effluvium
non-scarring alopecia arising during the growth (anagen) phase of the hair cycle. it may be associated with chemotherapy, exposure to radiation or heavy metals, poor nutrition, or various autoimmune conditions.
Patient EducationClinical
Hair Loss
You lose up to 100 hairs from your scalp every day. That's normal, and in most people, those hairs grow back. But many men -- and some women -- lose hair as they grow older. You can also lose your hair if you have certain diseases, such as thyroid problems, diabetes, or lupus.
Read the full article at MedlinePlus
Courtesy of MedlinePlus, a service of the U.S. National Library of Medicine.
Convert L65.1 to ICD-9-CMHistory
The closest ICD-9-CM equivalents under the General Equivalence Mappings.
Code HistoryHistory
Questions About L65.1Overview
What is the ICD-10 code for anagen effluvium?
The ICD-10-CM code for anagen effluvium is L65.1 (sometimes written as L651). It is billable on HIPAA-covered claims from October 1, 2026 through September 30, 2027.
Is L65.1 (Other nonscarring hair loss) a billable code?
Yes. This is a billable ICD-10-CM code, specific enough to report anagen effluvium on HIPAA-covered claims from October 1, 2026 through September 30, 2027.
What MS-DRG does L65.1 group to?
When anagen effluvium is the principal diagnosis on an inpatient stay, it groups to MS-DRG 607, 606, with relative weights from 0.8772 to 1.5721 depending on complications. Higher weights mean higher Medicare reimbursement.
Can L65.1 be reported with F63.3?
Not as a rule. The Excludes1 note at L65, which applies to L65.1, lists "trichotillomania (F63.3)". An Excludes1 note means the excluded code is never reported together with this one; the only exception is when the two conditions are unrelated to each other (Official Guidelines, Section I.A.12.a).